Search - tctmd.com

Displaying 441 - 460 of 708

Sort: Relevancy | Date

Presentation TCT 2016

Differences Between US and Japan in OAT Discontinuation and Risk of Major Bleeds, and Who are the Best LAA Closure Device Candidates in Both Countries

Presenter: Mitchell W. Krucoff, Shigeru Saito, Christopher B. Granger

October 30, 2016

Presentation TCT 2016

Epicardial Closure of the LAA With the Lariat: What Do we Know About Its Safety and Efficacy?

Presenter: Vivek Y. Reddy, Steven J. Yakubov, Matthew J. Price

October 30, 2016

Presentation TCT 2016

Surgical Approaches to LAA Closure: Techniques, Devices, and Results

Presenter: Vivek Y. Reddy, Steven J. Yakubov, Marc Gillinov

October 30, 2016

Presentation TCT 2016

Risk Scores for Stroke Risk and Bleeding in Atrial Fibrillation: Accuracy and Utility in Trials and the Real World

Presenter: Karl-Heinz Kuck, DJ Lakkireddy, Freek W.A. Verheugt, Christopher B. Granger

October 30, 2016

Presentation TCT 2016

Outcomes and Role of Ablation in the Treatment Approach to Atrial Fibrillation

Presenter: Karl-Heinz Kuck, DJ Lakkireddy, Freek W.A. Verheugt, Vivek Y. Reddy

October 30, 2016

Presentation TCT 2016

What are Valid Absolute and Relative Contraindications to Warfarin and NOACs?

Presenter: Karl-Heinz Kuck, DJ Lakkireddy, Freek W.A. Verheugt

October 30, 2016

Presentation TCT 2016

Warfarin and NOACS for Atrial Fibrillation: Efficacy, Complications, and Compliance

Presenter: Karl-Heinz Kuck, DJ Lakkireddy, Freek W.A. Verheugt, Michelle O'Donoghue

October 30, 2016

Presentation TCT 2016

Impact of LAA Exclusion on Neurohormonal Modulation

Presenter: Karl-Heinz Kuck, DJ Lakkireddy, Freek W.A. Verheugt

October 30, 2016

Presentation TCT 2016

Role of LAA in Atrial Arrhythmias: Origin and Maintenance

Presenter: Karl-Heinz Kuck, DJ Lakkireddy, Freek W.A. Verheugt

October 30, 2016

Presentation TCT 2016

Atrial Fibrillation: Scope of the Problem

Presenter: Karl-Heinz Kuck, DJ Lakkireddy, Freek W.A. Verheugt, Michael D. Ezekowitz

October 30, 2016

Presentation TCT 2016

Cases #7 and #8: When LAA closure Was Unsuccessful - Lessons Learned

Presenter: Matthew J. Price, Jason H. Rogers, Petr Neuzil

October 30, 2016

Presentation TCT 2016

Cases #5 and #6: Sheath Selection, Orientation, and Lobe Position to Optimize Occluder Deployment

Presenter: Matthew J. Price, Jason H. Rogers, Ramon Quesada

October 30, 2016

Presentation TCT 2016

Cases #3 and #4: Transseptal Puncture for LAA Closure - When Location Makes a Difference

Presenter: Matthew J. Price, Jason H. Rogers

October 30, 2016

Presentation TCT 2016

Cases #1 and #2: Insights From Baseline Imaging - When to Try and When to Walk Away

Presenter: Matthew J. Price, Jason H. Rogers, Jacqueline Saw

October 30, 2016

Presentation TCT 2016

Case #3: Transseptal Puncture for Left Atrial Appendage Closure

Presenter: Samir R. Kapadia, Horst Sievert, Brian K. Whisenant

October 30, 2016

Presentation TCT 2016

Rationale for and Case Examples of Combination Transcatheter Mitral Valve Repair Procedures and Left Atrial Appendage Closure

Presenter: Stephan Baldus, Vinod H. Thourani, Fabian Nietlispach

October 30, 2016

Presentation TCT 2016

Rationale for and Case Examples of Combination Transcatheter Mitral Valve and Left Atrial Appendage Closure

Presenter: Stephan Baldus, Vinod H. Thourani, Francesco Maisano

October 30, 2016

News Opinion Editor's Corner TCT 2016

TCT 2016: Inspiration and Perspiration Greet Left Main Stenting, Hoop Dreams, Valve Innovation, and Election Fever

Shelley Wood

October 24, 2016

Presentation TCT 2015

Alternatives to Anticoagulation: Left Atrial Appendage Occlusion Devices

Presenter: Gerhard C. Schuler, Matthew J. Price

October 14, 2015

Presentation TCT 2015

Data Gaps and Future Trial Pathways: Possible Study Designs for New Devices, Anticoagulation Ineligible Patients, and Comparative NOAC Data

Presenter: Nicole Ibrahim, Saibal Kar, Zoltan G. Turi

October 14, 2015

Advertisement

Differences Between US and Japan in OAT Discontinuation and Risk of Major Bleeds, and Who are the Best LAA Closure Device Candidates in Both Countries

Epicardial Closure of the LAA With the Lariat: What Do we Know About Its Safety and Efficacy?

Surgical Approaches to LAA Closure: Techniques, Devices, and Results

Risk Scores for Stroke Risk and Bleeding in Atrial Fibrillation: Accuracy and Utility in Trials and the Real World

Outcomes and Role of Ablation in the Treatment Approach to Atrial Fibrillation

What are Valid Absolute and Relative Contraindications to Warfarin and NOACs?

Warfarin and NOACS for Atrial Fibrillation: Efficacy, Complications, and Compliance

Impact of LAA Exclusion on Neurohormonal Modulation

Role of LAA in Atrial Arrhythmias: Origin and Maintenance

Atrial Fibrillation: Scope of the Problem

Cases #7 and #8: When LAA closure Was Unsuccessful - Lessons Learned

Cases #5 and #6: Sheath Selection, Orientation, and Lobe Position to Optimize Occluder Deployment

Cases #3 and #4: Transseptal Puncture for LAA Closure - When Location Makes a Difference

Cases #1 and #2: Insights From Baseline Imaging - When to Try and When to Walk Away

Case #3: Transseptal Puncture for Left Atrial Appendage Closure

Rationale for and Case Examples of Combination Transcatheter Mitral Valve Repair Procedures and Left Atrial Appendage Closure

Rationale for and Case Examples of Combination Transcatheter Mitral Valve and Left Atrial Appendage Closure

TCT 2016: Inspiration and Perspiration Greet Left Main Stenting, Hoop Dreams, Valve Innovation, and Election Fever

Alternatives to Anticoagulation: Left Atrial Appendage Occlusion Devices

Data Gaps and Future Trial Pathways: Possible Study Designs for New Devices, Anticoagulation Ineligible Patients, and Comparative NOAC Data

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content